{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:29:00Z","timestamp":1759026540829},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T00:00:00Z","timestamp":1241222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We analyzed the correlation between well\u2010established biological parameters of prognostic relevance in B\u2010cell chronic lymphocytic leukemia (CLL) [i.e. mutational status of the immunoglobulin heavy chain variable region (IgV<jats:sub>H<\/jats:sub>), ZAP\u201070\u2010 and CD38\u2010expression] and serum levels of CD26 (dipeptidyl peptidase IV, DPP IV) by evaluating the impact of these variables on the time to first treatment (TFT) in a series of 69 previously untreated Binet stage A B\u2010cell CLL patients. By using a commercial ELISA we found that with exception of a borderline significance for ZAP\u201070 (<jats:italic>P<\/jats:italic>\u2003=\u20030.07) and CD38 (<jats:italic>P<\/jats:italic>\u2003=\u20030.08), circulating levels of CD26 did not correlate with either Rai substages (<jats:italic>P<\/jats:italic>\u2003=\u20030.520) or other biomarker [\u03b22\u2010microglobulin (<jats:italic>P<\/jats:italic>\u2003=\u20030.933), LDH (<jats:italic>P<\/jats:italic>\u2003=\u20030.101), mutational status of IgV<jats:sub>H<\/jats:sub> (<jats:italic>P<\/jats:italic>\u2003=\u20030.320)]. Maximally selected log\u2010rank statistic plots identified a CD26 serum concentration of 371\u2003ng\/mL as the best cut\u2010off. This threshold allowed the identification of two subsets of patients with CD26 serum levels higher and lower that 371\u2003ng\/mL respectively, whose clinical outcome was different with respect to TFT (i.e. 46% and 71% at 5\u2003yr respectively; <jats:italic>P<\/jats:italic>\u2003=\u20030.005). Along with higher serum levels of CD26, the univariate Cox proportional hazard model identified absence of mutation in IgV<jats:sub>H<\/jats:sub> (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) as predictor of shorter TFT. As in multivariate analysis all these parameters maintained their discriminating power (mutational status of IgV<jats:sub>H,<\/jats:sub><jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001; soluble CD26, <jats:italic>P<\/jats:italic>\u2003=\u20030.02) their combined effect on clinical outcome was assessed. When three groups were considered: (1) Low\u2010risk group (<jats:italic>n<\/jats:italic>\u2003=\u200331), patients with concordant IgVH<jats:sub>mut<\/jats:sub> and low level of soluble CD26; (2) intermediate risk group (<jats:italic>n<\/jats:italic>\u2003=\u200326), patients with discordant pattern; (3) high\u2010risk group (<jats:italic>n<\/jats:italic>\u2003=\u200312), patients with concordant IgVH<jats:sub>unmut<\/jats:sub> and high level of soluble CD26, differences in the TFT were statistically significant, with a TFT at 5\u2003yr of respectively 88%, 51% and 43% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). Our results indicate that in early B\u2010cell CLL biological profile including among other parameters soluble CD26 may provide a useful insight into the complex interrelationship of prognostic variables. Furthermore, CD26 along with mutational status of IgV<jats:sub>H<\/jats:sub> can be adequately used to predict clinical behavior of patients with low risk disease.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2009.01273.x","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T09:02:28Z","timestamp":1241254948000},"page":"208-214","source":"Crossref","is-referenced-by-count":9,"title":["Serum level of CD26 predicts time to first treatment in early B\u2010chronic lymphocytic leukemia"],"prefix":"10.1111","volume":"83","author":[{"given":"Stefano","family":"Molica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Digiesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Cutrona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Antenucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Molica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Sperduti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01571.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01570.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.11.1865"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.13.7222"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910640508"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80180-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.12.4617.bloodjournal86124617"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1492"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690167"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.888"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01634.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62266-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1410"},{"key":"e_1_2_6_15_2","first-page":"307","article-title":"Soluble dipeptidyl peptidase IV (CD\u201026) in serum of patients with colorectal carcinoma","volume":"49","author":"De La Haba\u2010Rodr\u00edguez J","year":"2002","journal-title":"Neoplasma"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526355"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2607"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V78.4.895.895","article-title":"Progression and survival studies in early chronic lymphocytic leukemia","volume":"78","author":"Molica S","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-9473(02)00225-6"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90061-U"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.4049\/jimmunol.145.12.3963","article-title":"Cell surface modulation of CD26 by anti\u20101F7 monoclonal antibody: analysis of surface expression and human T cell activation","volume":"145","author":"Dang NH","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.2.649"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.147.9.2825","article-title":"1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation","volume":"147","author":"Dang NH","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00053.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.143.11.3430"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.15.8439"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.156.4.1349"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108605"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.03.003"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2009.01273.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2009.01273.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:13:08Z","timestamp":1696983188000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2009.01273.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1600-0609.2009.01273.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01273.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,3]]}}}